Brain metabolite alterations in infants born preterm with intrauterine growth restriction: association with

Rui V Simões1, Emma Muñoz-Moreno2, Mónica Cruz-Lemini3

  • 1BCNatal-Barcelona Center for Maternal-Fetal and Neonatal Medicine (Hospital Clínic and Hospital Sant Joan de Déu), Fetal i+D Fetal Medicine Research Center, IDIBAPS, University of Barcelona, Barcelona, Spain; Centre for Biomedical Research on Rare Diseases (CIBER-ER), Barcelona, Spain; Fundació Hospital Sant Joan de Déu, Barcelona, Spain.

Insights

Preterm infants with intrauterine growth restriction show altered brain metabolism and structure, impacting neurodevelopmental outcomes. These findings highlight potential risks and the need for further research into altered neurodevelopmental trajectories.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Medical Imaging

Background:

  • Intrauterine growth restriction (IUGR) and premature birth are independent risk factors for impaired neurodevelopment.
  • These conditions can occur together, potentially exacerbating neurodevelopmental deficits.
  • Understanding the brain's metabolic and structural changes in these infants is crucial for early intervention.

Purpose of the Study:

  • To assess frontal lobe metabolic profiles in 1-year-old infants with IUGR born prematurely.
  • To compare these profiles with premature and term-born adequate-for-gestational-age controls.
  • To associate metabolic profiles with brain structure, biophysics, and 2-year neurodevelopmental outcomes.

Main Methods:

  • Brain MRI and magnetic resonance spectroscopy (MRS) were performed on 1-year-old infants (IUGR preterm, preterm AGA, term AGA).
  • T1-weighted, diffusion-weighted images, and proton spectra from the frontal lobe were acquired.
  • Neurodevelopment was assessed at 2 years using the Bayley Scales of Infant and Toddler Development, 3rd Edition.

Main Results:

  • IUGR preterm infants exhibited smaller brain volumes and increased white matter diffusivity.
  • Lower N-acetylaspartate (NAA) levels were observed in IUGR preterm infants compared to preterm AGA controls.
  • Metabolite alterations correlated with reduced gray matter, increased diffusivity, and altered white matter integrity, alongside a trend for poorer neurodevelopmental outcomes.

Conclusions:

  • Preterm IUGR infants display altered brain metabolite profiles during a critical maturation period.
  • These metabolic changes are linked to structural and biophysical brain parameters.
  • Altered neurodevelopmental trajectories are suggested in preterm IUGR and preterm AGA infants compared to term AGA infants.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
985
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K